Skip to Main Content

Paper Details

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.
Clin Infect Dis
30
2023
Author NameAffiliation
Elodie GhedinNational Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 1

Datasets

Release 1.2